NCT04996823 2025-12-04Axitinib + Ipilimumab in Advanced MelanomaH. Lee Moffitt Cancer Center and Research InstitutePhase 2 Recruiting25 enrolled
NCT00094107 2012-06-26Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic MelanomaPfizerPhase 2 Completed32 enrolled 9 charts